Accessibility Menu
 
Eckert & Ziegler Se logo

Eckert & Ziegler Se

(ETR) EUZ

Current Price$15.07
Market Cap$886.67M
Since IPO (1999)+1,285%
5 Year-36%
1 Year-19%
1 Month+3%

Eckert & Ziegler Se Financials at a Glance

Market Cap

$886.67M

Revenue (TTM)

$304.47M

Net Income (TTM)

$39.75M

EPS (TTM)

$0.63

P/E Ratio

22.30

Dividend

$0.50

Beta (Volatility)

0.01 (Low)

Price

$15.07

Volume

197,767

Open

$14.30

Previous Close

$15.07

Daily Range

$14.01 - $15.16

52-Week Range

$13.30 - $23.25

EUZ News

No articles available.

EUZ: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Eckert & Ziegler Se

Industry

Healthcare Equipment and Supplies

Employees

1,112

CEO

Harald Hasselmann, PhD

Headquarters

Berlin, 13125, DE

EUZ Financials

Key Financial Metrics (TTM)

Gross Margin

47%

Operating Margin

21%

Net Income Margin

13%

Return on Equity

17%

Return on Capital

17%

Return on Assets

9%

Earnings Yield

4.48%

Dividend Yield

0.01%

Payout Ratio

26.23%

Stock Overview

Market Cap

$886.67M

Shares Outstanding

62.57M

Volume

197.77K

Short Interest

0.00%

Avg. Volume

117.01K

Financials (TTM)

Gross Profit

$143.16M

Operating Income

$61.07M

EBITDA

$77.38M

Operating Cash Flow

$66.57M

Capital Expenditure

$17.19M

Free Cash Flow

$49.38M

Cash & ST Invst.

$118.36M

Total Debt

$55.34M

Eckert & Ziegler Se Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$75.31M

+7.4%

Gross Profit

$34.15M

+0.4%

Gross Margin

45.35%

N/A

Market Cap

$886.67M

N/A

Market Cap/Employee

$817.21K

N/A

Employees

1,085

N/A

Net Income

$8.46M

+58.2%

EBITDA

$19.39M

+2.4%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$74.63M

+63.3%

Accounts Receivable

$52.40M

+10.4%

Inventory

$46.56M

+2.0%

Long Term Debt

$37.04M

-13.2%

Short Term Debt

$9.37M

+1.6%

Return on Assets

8.79%

N/A

Return on Invested Capital

17.28%

N/A

Free Cash Flow

$10.61M

-54.1%

Operating Cash Flow

$17.59M

-32.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
5CV.FCureVac N.V.
$3.91+0.00%
5CV.DECureVac N.V.
$3.91+0.72%
4LL.FTeladoc Health, Inc.
$4.81-1.42%
RHK.DERhoen-Klinikum AG
$12.30-1.60%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$41.23-0.07%
EEIQEpicQuest Education Group International
$8.44+2.09%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.92+0.08%
QQQInvesco QQQ Trust
$573.79-0.02%

Questions About EUZ

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.